FDA To Resume Onsite Foreign Inspections After Hitting Domestic Goals

By Kelly Lienhard / November 23, 2021 at 6:26 PM
FDA conducted twice as many domestic facility inspections this year than it had previously planned, yet 60 applications are still on hold awaiting onsite inspections, 90% involving foreign facilities and four of which are mission critical, the agency reveals in an inspection roadmap update issued this week . FDA plans to resume priority onsite foreign inspections, including surveillance and application-related ones, beginning in February 2022 if it is safe to travel internationally. As for domestic inspections, FDA will use risk...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.